| Income Statement | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Total revenues | 26 | 129 | ||
| General and administrative | 5,173 | 4,533 | ||
| Research and development | 19,646 | 18,428 | ||
| Total operating expenses | 24,819 | 22,961 | ||
| Loss from operations | -24,793 | -22,832 | ||
| Interest income and other, net | 1,914 | 2,147 | ||
| Net loss | -22,879 | -20,685 | ||
| Unrealized gain (loss) on debt investments, net | 466 | -30 | ||
| Comprehensive loss | -22,413 | -20,715 | ||
| Basic eps | -0.26 | -0.23 | ||
| Diluted eps | -0.26 | -0.23 | ||
| Basic average shares | 89,701,117 | 89,630,959 | ||
| Diluted average shares | 89,701,117 | 89,630,959 | ||
null (CMRX)
null (CMRX)